B. Metzler seel. Sohn & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.6M | Buy |
265,133
+26,456
| +11% | +$2.12M | 0.15% | 80 |
|
|
2025
Q4 | $22.8M | Buy |
238,677
+5,358
| +2% | +$525K | 0.2% | 68 |
|
|
2025
Q3 | $22.8M | Buy |
233,319
+2,765
| +1% | +$286K | 0.2% | 66 |
|
|
2025
Q2 | $24.8M | Buy |
230,554
+1,160
| +0.5% | +$117K | 0.24% | 62 |
|
|
2025
Q1 | $23.1M | Buy |
229,394
+3,683
| +2% | +$371K | 0.24% | 63 |
|
|
2024
Q4 | $20.2M | Sell |
225,711
-59,979
| -21% | -$5.28M | 0.21% | 68 |
|
|
2024
Q3 | $23.9M | Buy |
285,690
+10,771
| +4% | +$849K | 0.24% | 66 |
|
|
2024
Q2 | $21.2M | Buy |
274,919
+21,989
| +9% | +$1.61M | 0.2% | 65 |
|
|
2024
Q1 | $17.3M | Sell |
252,930
-12,514
| -5% | -$805K | 0.19% | 69 |
|
|
2023
Q4 | $15.3M | Buy |
265,444
+96,613
| +57% | +$5.16M | 0.2% | 67 |
|
|
2023
Q3 | $8.91M | Sell |
168,831
-6,298
| -4% | -$330K | 0.13% | 97 |
|
|
2023
Q2 | $9.47M | Sell |
175,129
-7,177
| -4% | -$375K | 0.13% | 109 |
|
|
2023
Q1 | $9.12M | Buy |
182,306
+37,553
| +26% | +$1.77M | 0.14% | 101 |
|
|
2022
Q4 | $6.7M | Buy |
144,753
+39,410
| +37% | +$1.71M | 0.11% | 125 |
|
|
2022
Q3 | $4.08M | Sell |
105,343
-35,476
| -25% | -$1.42M | 0.07% | 175 |
|
|
2022
Q2 | $5.25M | Buy |
140,819
+4,633
| +3% | +$189K | 0.09% | 156 |
|
|
2022
Q1 | $6.03M | Sell |
136,186
-2,423
| -2% | -$105K | 0.08% | 160 |
|
|
2021
Q4 | $5.96M | Buy |
138,609
+34,685
| +33% | +$1.46M | 0.08% | 162 |
|
|
2021
Q3 | $4.51M | Buy |
103,924
+19,803
| +24% | +$876K | 0.07% | 177 |
|
|
2021
Q2 | $3.6M | Sell |
84,121
-2,704
| -3% | -$114K | 0.05% | 203 |
|
|
2021
Q1 | $3.36M | Sell |
86,825
-950
| -1% | -$36K | 0.06% | 206 |
|
|
2020
Q4 | $3.13M | Buy |
+87,775
| New | +$3.16M | 0.06% | 193 |
|
Other funds holding BSX
VCM
VPM
